Skip to main content
SpringerLink
Log in

Antineoplastics/pirarubicin

Lack of efficacy : case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hong L, et al. Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: A case report. Journal of Gastrointestinal Oncology 13: 1499-1504, No. 3, Jun 2022. Available from: URL: https://jgo.amegroups.com/article/view/65332/html

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/pirarubicin. Reactions Weekly 1921, 46 (2022). https://doi.org/10.1007/s40278-022-22040-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-22040-z

Search

Navigation